CRISPR Meets Synthetic Biology: A Conversation with MIT’s Christopher Voigt
Type
Blog Post
Published
April 22, 2015, 2:06 p.m.
...As Christopher Voigt explains it, his lab at the Massachusetts Institute of Technology has been “working...proteins. There are still things we haven’t solved that stop it from being used. One thing is that Cas9 is toxic...